Literature DB >> 18615552

Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.

Yuji Miura, Masahiro Kami, Ron Yotsuya, Nobuo Toda, Tsunehiko Komatsu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18615552     DOI： 10.1002/ajh.21229

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C.

Authors:  Cheng-Shyong Chang; Sheng-Lei Yan; Hsuan-Yu Lin; Fu-Lien Yu; Chien-Yu Tsai
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

2.  Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporine.

Authors:  Keiji Hirai; Susumu Ookawara; Haruhisa Miyazawa; Kiyonori Ito; Yuichiro Ueda; Yoshio Kaku; Taro Hoshino; Shun-Ichi Kimura; Izumi Yoshida; Sachiko Kakuta; Yoshiyuki Morishita; Kaoru Tabei
Journal:  CEN Case Rep       Date:  2015-09-15

3.  Pure red cell aplasia caused by ribavirin and interferon treatment.

Authors:  Andrew J Skabelund; Timothy R Hauser; Kevin J Goist
Journal:  Clin J Gastroenterol       Date:  2011-07-30

4.  Measurement of anti-erythropoiesis-stimulating agent IgG4 antibody as an indicator of antibody-mediated pure red cell aplasia.

Authors:  Dohan K Weeraratne; Andrew J Kuck; Narendra Chirmule; Daniel T Mytych
Journal:  Clin Vaccine Immunol       Date:  2012-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.